Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 6
2011 6
2012 4
2013 1
2014 3
2015 3
2016 5
2017 6
2018 6
2019 2
2020 12
2021 19
2022 7
2023 13
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapy as a partner for HER2-directed therapies.
Clifton GT, Peoples AGE. Clifton GT, et al. Expert Rev Anticancer Ther. 2021 Jul;21(7):739-746. doi: 10.1080/14737140.2021.1894932. Epub 2021 Mar 9. Expert Rev Anticancer Ther. 2021. PMID: 33666116 Review.
Critical issues in cancer vaccine trial design.
Clifton GT, Kohrt HE, Peoples GE. Clifton GT, et al. Vaccine. 2015 Dec 16;33(51):7386-7392. doi: 10.1016/j.vaccine.2015.09.019. Epub 2015 Sep 19. Vaccine. 2015. PMID: 26392010 Review.
Developing a definition of immune exclusion in cancer: results of a modified Delphi workshop.
Clifton GT, Rothenberg M, Ascierto PA, Begley G, Cecchini M, Eder JP, Ghiringhelli F, Italiano A, Kochetkova M, Li R, Mechta-Grigoriou F, Pai SI, Provenzano P, Puré E, Ribas A, Schalper KA, Fridman WH. Clifton GT, et al. J Immunother Cancer. 2023 Jun;11(6):e006773. doi: 10.1136/jitc-2023-006773. J Immunother Cancer. 2023. PMID: 37290925 Free PMC article.
Towards a consensus definition of immune exclusion in cancer.
Tiwari A, Oravecz T, Dillon LA, Italiano A, Audoly L, Fridman WH, Clifton GT. Tiwari A, et al. Among authors: clifton gt. Front Immunol. 2023 Mar 22;14:1084887. doi: 10.3389/fimmu.2023.1084887. eCollection 2023. Front Immunol. 2023. PMID: 37033994 Free PMC article. Review.
Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis.
Carpenter EL, Van Decar S, Adams AM, O'Shea AE, McCarthy P, Chick RC, Clifton GT, Vreeland T, Valdera FA, Tiwari A, Hale D, Kemp Bohan P, Hickerson A, Smolinsky T, Thomas K, Cindass J, Hyngstrom J, Berger AC, Jakub J, Sussman JJ, Shaheen MF, Yu X, Wagner TE, Faries M, Peoples GE. Carpenter EL, et al. Among authors: clifton gt. J Immunother Cancer. 2023 Aug;11(8):e006665. doi: 10.1136/jitc-2023-006665. J Immunother Cancer. 2023. PMID: 37536936 Free PMC article. Clinical Trial.
AE37: a novel T-cell-eliciting vaccine for breast cancer.
Sears AK, Perez SA, Clifton GT, Benavides LC, Gates JD, Clive KS, Holmes JP, Shumway NM, Van Echo DC, Carmichael MG, Ponniah S, Baxevanis CN, Mittendorf EA, Papamichail M, Peoples GE. Sears AK, et al. Among authors: clifton gt. Expert Opin Biol Ther. 2011 Nov;11(11):1543-50. doi: 10.1517/14712598.2011.616889. Epub 2011 Sep 6. Expert Opin Biol Ther. 2011. PMID: 21895539 Review.
The GP2 peptide: a HER2/neu-based breast cancer vaccine.
Clive KS, Tyler JA, Clifton GT, Holmes JP, Ponniah S, Peoples GE, Mittendorf EA. Clive KS, et al. Among authors: clifton gt. J Surg Oncol. 2012 Apr 1;105(5):452-8. doi: 10.1002/jso.21723. J Surg Oncol. 2012. PMID: 22441896 Review.
81 results